Lisa Su 10b5-1 Plan: Option Exercise at $34.19 and $160+ Share Sales
Rhea-AI Filing Summary
Insider activity by AMD CEO Lisa T. Su: The report shows the exercise of 224,727 stock options at an exercise price of $34.19, resulting in an acquisition of those shares. The Reporting Person sold a total of 225,000 shares in multiple transactions at weighted-average prices ranging from about $162.27 to $165.59, with reported weighted-average sale prices of $163.06, $163.76, $164.65, and $165.45 across the respective sale tranches. After these transactions, the Reporting Person beneficially owns 3,359,748 shares directly, plus additional shares held indirectly through several Grantor Retained Annuity Trusts and GRATs.
Positive
- Exercise of 224,727 options at $34.19 indicates long-term compensation realization and continued stake accumulation.
- Large retained direct ownership: Reporting Person continues to hold 3,359,748 shares directly plus material indirect trust holdings.
Negative
- Sales of 225,000 shares executed at prices around $162–$165 represent significant insider dispositions under the 10b5-1 plan.
- Substantial share turnover in a short period may be viewed by some investors as monetization that reduces insider-held float.
Insights
TL;DR: CEO exercised long-dated options and sold a tranche of shares under a 10b5-1 plan; holdings remain substantial.
The exercise of 224,727 options at $34.19 indicates realization of long-term compensation rather than an opportunistic market sale, particularly since the exercise and the subsequent sales were executed pursuant to a Rule 10b5-1 plan. The CEO still holds over 3.35 million shares directly, with additional indirect holdings via multiple GRAT/GRAT-like trusts, preserving alignment with shareholders. The disclosed sales total 225,000 shares executed across price bands near $162–$165, which is a meaningful but not controlling percentage of reported holdings.
TL;DR: Option exercise at low exercise price plus high-price sales increased liquidity while maintaining concentrated ownership.
The option exercise at $34.19 created 224,727 common shares acquired, while contemporaneous sales of 225,000 shares at weighted-average prices in the low-$160s likely generated significant proceeds. Net direct holdings remain large at 3,359,748 shares, supported by additional indirect trust holdings (several six-figure positions). For investors, the transactions reflect routine executive monetization under a pre-established plan, not an unplanned disposal signaling distress.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option Grant | 224,727 | $0.00 | $0.00 |
| Exercise | Common Stock | 224,727 | $34.19 | $7.68M |
| Sale | Common Stock | 19,620 | $163.06 | $3.20M |
| Sale | Common Stock | 138,093 | $163.76 | $22.61M |
| Sale | Common Stock | 65,787 | $164.65 | $10.83M |
| Sale | Common Stock | 1,500 | $165.45 | $248K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (7)
- F1. The stock option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024.
- F2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2024.
- F3. Transaction executed in multiple trades at prices ranging from $162.27 to $163.26 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F4. Transaction executed in multiple trades at prices ranging from $163.27 to $164.26 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F5. Transaction executed in multiple trades at prices ranging from $164.27 to $165.26 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F6. Transaction executed in multiple trades at prices ranging from $165.29 to $165.59 per share, inclusive. The price reported in column 4 above reflects the weighted average sale price per share. The Reporting Person hereby undertakes to provide the SEC staff, the Issuer or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- F7. The options vest 1/3 on each of August 9, 2020, 2021 and 2022.
AI-generated analysis. How Rhea-AI works. Not financial advice.
